Anton is the CEO and a founding member of Moximed Inc. Prior to joining Moximed, Anton held a variety of R&D management positions at Abbott Vascular, a division of Abbott Laboratories, including Director of Research and Development for Coronary Technologies. In 2005, Anton was inducted into Abbott Laboratories Volweiler Society, a society established to recognize the company’s most distinguished scientists and engineers, and was awarded researcher of the year for outstanding contributions made to Abbott Laboratories vascular stent research. Anton started his career in medical devices at MedNova Ltd. in 1998, where he led the Carotid Stent Development Program. Anton is a prolific inventor, having more than 90 filed or issued US & International patents and multiple scientific publications. Dr. Clifford has holds a BSc and PhD in Materials Science from the University of Limerick, Ireland.
Christine’s expertise is in improving business performance while developing a positive, goal orientated corporate culture both domestically and internationally. Christine joined Moximed Inc. in February 2008. Christine has over 20 years experience in Business and Human Capital Management. Prior to joining Moximed Inc., Christine held the position of Director of HR and Administration for St. Francis Medical Technologies. Christine played a pivotal role in the acquisition of St. Francis by Kyphon, Inc and was a key member of the transition team following the sale. Prior to that, Christine held Business Management roles of increasing responsibility in the ophthalmology field. Christine holds a BS in Behavioral Science from California State Polytechnic University, Pomona and a BA in Business Administration from the University of California, Los Angeles.
Luigi joined Moximed Inc. in January 2011 with over 15 years experience in the orthopedic field. Prior to joining Moximed Inc., Luigi was the VP of Sales and Strategic Business Development for Smith & Nephew AG where he was responsible for Southern Europe, overseeing revenues of $130 million and 220 employees. Prior to that, he held management positions at Plus Orthopedics AG and Centerpulse Orthopedics, Italy. Luigi is also the Co-Founder for Sevika Medical AG. He has achieved an excellent reputation and a history of success throughout the industry. Luigi holds a Master of Science in Mechanical Engineering from the Federal Institute of Technology-ETH Zurich, he is fluent in five languages and currently resides in Zurich.
Keith joined Moximed Inc. in March 2010. Keith has extensive experience in the medical device field, with a cross-functional background in multiple industry segments. Prior to Moximed, Keith was a Manager of Business Development for Maquet Cardiovascular (formerly the Cardiac and Vascular Surgery Divisions of Boston Scientific). He has previous product marketing and clinical sales experience with Guidant’s Vascular Intervention, Cardiac Rhythm Management, and Cardiac Surgery business units. Prior to that, he held roles in R&D and Project Management for Guidant. Keith holds an MBA from The Tuck School of Business at Dartmouth and a BS in Mechanical Engineering from the University of California, Berkeley.
Nancy is a senior management leader and regulatory/clinical/quality advisor with more than 25 years of experience in obtaining approvals of devices, in vitro diagnostics, drugs, biologics and combination products for companies ranging from start-ups to Fortune 500 in neurology, oncology, orthopedics, urology, cardiology, and pulmonology. She has held numerous Vice President positions in Regulatory and Clinical Affairs, and Quality Assurance. She has worked for Moximed, CardioKinetix, NeoTract, Neuraltus, Broncus, Aerogen, Becton Dickinson, Genzyme, and Syntex/Syva. Nancy earned her Masters Public Health and Law at Harvard School of Public Health; her Juris Doctorate, with Health Law Concentration, at Boston University; and her Bachelor of Science degree in Cell and Molecular Biology at San Francisco State University.
Ms. Yamut has more than 20 years of experience in the medical device industry. She specializes in getting start-up companies their regulatory/clinical approvals to either begin a clinical trial or commence a product commercial launch, domestically and internationally. Her experience includes authoring various FDA submissions, running clinical operations, and developing quality systems. Ms. Yamut also has extensive experience in gaining OUS approvals for clinical investigations and/or product launch in Europe, North America, South America, Australia, Asia, and Africa. Prior to joining Moximed, she has held several management positions at various start-up companies which include Vice President of Regulatory and Clinical Affairs at CHF Technologies and Cabochon Aesthetics (acquired by Ulthera), Sr. Director of Clinical and Regulatory Affairs at Spinal Kinetics and Relievant MedSystems, Director of Regulatory and Quality Affairs at Cardiovention, Inc., and Sr. Manager of Regulatory and Quality Affairs at Kyphon, Inc. (acquired by Medtronic) and General Surgical Innovations (acquired by Tyco Healthcare). Ms. Yamut studied Business Management and Administration at University of California and at Stanford Graduate School of Business.